Kingdon Capital Management’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-100,000
| Closed | -$3.78M | – | 89 |
|
|
2022
Q1 | $3.78M | Buy |
100,000
+48,668
| +95% | +$1.84M | 0.39% | 43 |
|
|
2021
Q4 | $2.03M | Buy |
+51,332
| New | +$2.03M | 0.23% | 55 |
|
|
2021
Q3 | – | Sell |
-8,317
| Closed | -$204K | – | 80 |
|
|
2021
Q2 | $204K | Sell |
8,317
-31,683
| -79% | -$777K | 0.02% | 57 |
|
|
2021
Q1 | $730K | Buy |
+40,000
| New | +$730K | 0.07% | 53 |
|